Parotid gland cancer treatment with immunotherapy

One of the main functions of the human immune system is to detect and fight against cancerous cells inside the organism. Unfortunately, for various reasons, the inner immune response might be insufficient to fight against cancer successfully. So, medical practitioners began seeking ways to help increase the immune system's ability to fight cancer. A set of such methods nowadays is called immunotherapy. The therapy is effectively used for parotic cancer treatment in selected patients. That usually works combined with other methods, such as surgery or radiation. Sometimes oncologists use immune drugs for advanced stages to prolong the patient's life. Currently, many different approaches to immunotherapy, like monoclonal antibodies, are similar to targeted therapy, as they block some of the vital proteins inside the tumor and boost the immune system. Many other types of immunotherapy, including immune checkpoint inhibitors and PD-1 inhibitors, aim to decrease the activity of receptors that prevent immune cells from finding and attacking cancerous cells. Typically, the patient gets a treatment session every 3 to 6 weeks. A single treatment procedure might take up to a few hours, as drugs must be delivered slowly via dropper or intravenous injection. Also, the patient will get all the necessary treatment that will help decrease the severity of parotid gland cancer symptoms during therapy.